News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
683,322 Results
Type
Article (38974)
Company Profile (276)
Press Release (644072)
Section
Business (203827)
Career Advice (1985)
Deals (35361)
Drug Delivery (84)
Drug Development (80771)
Employer Resources (168)
FDA (16085)
Job Trends (14797)
News (344474)
Policy (32430)
Tag
Academia (2530)
Alliances (49039)
Alzheimer's disease (1215)
Approvals (16004)
Artificial intelligence (116)
Bankruptcy (352)
Best Places to Work (11465)
Biotechnology (196)
Breast cancer (107)
Cancer (901)
Cardiovascular disease (81)
Career advice (1656)
Cell therapy (198)
Clinical research (63923)
Collaboration (326)
Compensation (168)
COVID-19 (2522)
Cystic fibrosis (78)
Data (862)
Diabetes (134)
Diagnostics (6096)
Earnings (84159)
Employer resources (146)
Events (108852)
Executive appointments (247)
FDA (16529)
Funding (289)
Gene therapy (149)
GLP-1 (559)
Government (4318)
Healthcare (18652)
Infectious disease (2597)
Inflammatory bowel disease (102)
Interviews (308)
IPO (16274)
Job creations (3622)
Job search strategy (1415)
Layoffs (408)
Legal (7848)
Lung cancer (154)
Manufacturing (151)
Medical device (13147)
Medtech (13152)
Mergers & acquisitions (19109)
Metabolic disorders (364)
Neuroscience (1456)
NextGen Class of 2024 (6496)
Non-profit (4462)
Northern California (1206)
Obesity (216)
Opinion (176)
Patents (94)
People (56126)
Phase I (19824)
Phase II (28145)
Phase III (21015)
Pipeline (212)
Postmarket research (2553)
Preclinical (8429)
Radiopharmaceuticals (234)
Rare diseases (180)
Real estate (5888)
Regulatory (21442)
Research institute (2307)
Resumes & cover letters (349)
Southern California (1082)
Startups (3560)
United States (11658)
Vaccines (537)
Weight loss (160)
Date
Today (236)
Last 7 days (851)
Last 30 days (2912)
Last 365 days (35685)
2024 (30409)
2023 (40074)
2022 (51173)
2021 (55712)
2020 (54087)
2019 (46541)
2018 (35021)
2017 (32112)
2016 (31483)
2015 (37553)
2014 (31319)
2013 (26348)
2012 (28572)
2011 (29265)
2010 (27328)
Location
Africa (713)
Arizona (187)
Asia (37031)
Australia (6037)
California (2727)
Canada (1178)
China (209)
Colorado (117)
Connecticut (122)
Europe (79240)
Florida (394)
Georgia (100)
Illinois (306)
Indiana (177)
Kansas (95)
Maryland (515)
Massachusetts (2227)
Michigan (143)
Minnesota (250)
New Jersey (827)
New York (840)
North Carolina (665)
Northern California (1206)
Ohio (127)
Pennsylvania (747)
South America (1091)
Southern California (1082)
Texas (383)
Utah (80)
Washington State (322)
683,322 Results for "3sbio inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
3SBio announces 2022 annual results, with revenue rising 7.5% year on year and normalized net profit attributable to parents jumping 25.2%
Chinese leading biopharmaceutical company 3SBio announced its 2022 annual results.
March 21, 2023
·
10 min read
Numab and 3SBio’s Sunshine Guojian Expand Partnership to Develop Novel T Cell Engager NM28
Numab Therapeutics AG and 3SBio Inc. announced that 3SBio’s subsidiary Sunshine Guojian Pharmaceutical Co., Ltd. exercised its option for an exclusive regional license for the development and commercialization of NM28, a potential best-in-class bivalent mesothelin -targeting CD3 T cell engager.
December 14, 2021
·
4 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
Lophos Holdings Inc. Announces the Completion of Securities Purchase Agreement with ThreeD Capital Inc.
Lophos Holdings Inc. (CSE: MESC) (“Lophos” or the “Company”), a Canadian bioscience company focused on the cultivation and sale of Lophophora williamsii (“Peyote”) and ThreeD Capital Inc. (CSE: IDK) (OTCQB: IDKFF) (“ThreeD”), a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, are pleased to announce the completion of its previously announced Securities Purchase Agreement (the “Agreement”).
June 20, 2024
·
4 min read
Press Releases
Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)
October 8, 2024
·
14 min read
Press Releases
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium
November 4, 2024
·
1 min read
Business
3SBio announces 2021 interim results, with strong growth in core businesses and significant progress in clinical development
Chinese leading biopharmaceutical company 3SBio (01530.HK) today unveiled its 2021 interim results.
August 26, 2021
·
13 min read
Press Releases
Boston Scientific Announces Agreement to Acquire Cortex, Inc.
November 5, 2024
·
7 min read
Vivos Inc. Submits the Application to the FDA for Authority to Initiate Human Clinical Trials
Vivos Inc. (OTCQB: RDGL), Vivos Inc. filed the application for an Investigational Device Exemption (“IDE”).
June 28, 2024
·
4 min read
1 of 68,333
Next
